Product Information
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.6645 per EA under NDC 75834026460. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on Feb 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 200 mg/1; ug/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834026460
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
Generic (ANDA)
FDA Application
ANDA205143FDA Approved
2/19/2020
TE Code
AB
On Market Since
7/15/2021
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 48.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6645 per EA |
|---|---|
| All-time high | $1.5755 (Apr 10, 2024) |
| All-time low | $0.6645 (Sep 23, 2026) |
| 52-week high | $1.0044 |
| 52-week low | $0.6645 |
| Median price | $0.9907 |
| Average price | $0.9915 |
| Largest weekly change | +59.0% (Mar 20, 2024) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nivagen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac sodium and misoprostol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.6645 per EA (NDC 75834026460), effective Sep 30, 2026.
How has the price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has declined 48.6%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
Since Sep 21, 2022, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has ranged from a low of $0.6645 (Sep 23, 2026) to a high of $1.5755 (Apr 10, 2024), with a median of $0.9907 per EA.
Are there cheaper alternatives to DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET (NDC 75834026460) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.